Vaidya Sane Ayurved Laboratories Ltd Financials

Vaidya Sane Ayurved Laboratories Ltd Financial Statement

Vaidya Sane Ayurved Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Vaidya Sane Ayurved Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	97.33	99.03	74.71
Operating Expenses Annual	94.16	90.69	67.81
Operating Profit Annual	4.73	9.70	7.24
Interest Annual	0.25	0.19	0.20
Depreciation	2.13	1.79	1.67
Net Profit Annual	1.05	5.19	3.47
Tax Annual	0.41	1.72	1.28

Particulars	Mar 2024
Total Revenue Annual	97.33
Operating Expenses Annual	94.16
Operating Profit Annual	4.73
Interest Annual	0.25
Depreciation	2.13
Net Profit Annual	1.05
Tax Annual	0.41

Vaidya Sane Ayurved Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	1.75	2.56	0.90
Cash Flow from Operations	-3.11	-0.43	-13.31
Cash Flow from Investing	0.02	1	-7.52
Cash Flow from Financing	14.46	-1.38	22.49
Cash Flow at the End	13.12	1.75	2.56

Particulars	Mar 2024
Cash Flow at the Beginning	1.75
Cash Flow from Operations	-3.11
Cash Flow from Investing	0.02
Cash Flow from Financing	14.46
Cash Flow at the End	13.12

Vaidya Sane Ayurved Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	5.53	10.46	10.25
PBIT Margin (%)	2.41	7.84	7.19
PBT Margin (%)	0.22	-1.38	-4.24
Net PROFIT Margin (%)	1.08	5.24	4.64
Return On Networth / Equity (%)	1.88	13.54	15.20
Return On Networth /Employed (%)	4.70	19.16	20.93
Return On Assets (%)	2.09	12.79	13.52
Total Debt / Equity (X)	0.02	0.02	0.05
Asset Turnover Ratio (%)	1.94	2.44	2.91

Particulars	Mar 2024
PBDIT Margin (%)	5.53
PBIT Margin (%)	2.41
PBT Margin (%)	0.22
Net PROFIT Margin (%)	1.08
Return On Networth / Equity (%)	1.88
Return On Networth /Employed (%)	4.70
Return On Assets (%)	2.09
Total Debt / Equity (X)	0.02
Asset Turnover Ratio (%)	1.94

Vaidya Sane Ayurved Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	22.08	20.95	17.01
Total Current Assets Annual	32.20	28.82	25.48
Non Current Assets Annual	39.20	26.46	24.53
Total Shareholders Funds Annual	55.02	40.81	35.88
Total Assets Annual	71.39	55.28	50.01

Particulars	Mar 2024
Fixed Assets Annual	22.08
Total Current Assets Annual	32.20
Non Current Assets Annual	39.20
Total Shareholders Funds Annual	55.02
Total Assets Annual	71.39

Vaidya Sane Ayurved Laboratories Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Jan 15, 2025, Vaidya Sane Ayurved Laboratories Ltd has a market capitalization of 182.93 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Vaidya Sane Ayurved Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.03.

In FY 2024 , Vaidya Sane Ayurved Laboratories Ltd recorded a total revenue of approximately 97.33 Cr marking a significant milestone in the company's financial performance.

Vaidya Sane Ayurved Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.1% annually, respectively..

Vaidya Sane Ayurved Laboratories Ltd's current PE ratio is 174.22.

Vaidya Sane Ayurved Laboratories Ltd's ROCE averaged 11.2% from the FY ending March 2022 to 2024, with a median of 13.4%. It peaked at 17.3% in March 2023, reflecting strong capital efficiency over the period..

Vaidya Sane Ayurved Laboratories Ltd's latest EBIT is Rs. 1.70 Cr, surpassing the average EBIT of Rs. 4.58 Cr over the 5 years..